Inflammatory and Oxidative Pathways Are New Drug Targets in Multiple Episode Schizophrenia and Leaky Gut, Klebsiella pneumoniae, and C1q Immune Complexes Are Additional Drug Targets in First Episode Schizophrenia
- PMID: 33675500
- DOI: 10.1007/s12035-021-02343-8
Inflammatory and Oxidative Pathways Are New Drug Targets in Multiple Episode Schizophrenia and Leaky Gut, Klebsiella pneumoniae, and C1q Immune Complexes Are Additional Drug Targets in First Episode Schizophrenia
Abstract
Breakdown of paracellular and vascular pathways and activated neuroimmune and oxidative pathways was established in (deficit) schizophrenia. The aim of this study was to delineate (a) the differences in these pathways between stable-phase, first (FES) and multiple (MES) episode schizophrenia and (b) the pathways that determine the behavioral-cognitive-physical-psychosocial (BCPS) deterioration in FES/MES. This study included 21 FES and 58 FES patients and 40 healthy controls and measured indicants of serum C1q circulating immune complexes (CIC), leaky gut, immune activation, and oxidative stress toxicity (OSTOX). We constructed a BCPS-worsening index by extracting a latent vector from symptomatic, neurocognitive, and quality of life data. FES was associated with higher IgA CIC-C1q, IgA directed to cadherin, catenin, and plasmalemma vesicle-associated protein, and IgA/IgM to Gram-negative bacteria as compared with FES and controls. In FES patients, the BCPS-worsening score was predicted (48.7%) by IgA to Klebsiella pneumoniae and lowered paraoxonase 1 activity. In MES patients, the BCPS-worsening score was explained (42.7%) by increased tumor necrosis factor-α, OSTOX, and number of episodes. In schizophrenia, 34.0% of the variance in the BCPS-worsening score was explained by IgA to K. pneumoniae, OSTOX, and number of episodes. Increased IgA to K. pneumoniae was the single best predictor of residual psychotic symptoms in FES and MES. This study delineated different mechanistic processes in FES, including breakdown of adherens junctions, bacterial translocation, and IgA CIC-C1q formation, and MES, including immune and oxidative neurotoxic pathways. FES and MES comprise different staging subtypes, i.e., FES and MES with and without worsening.
Keywords: Antioxidants; Autoimmune; IgM; Inflammation; Neuroimmune; Oxidative and nitrosative stress; Tryptophan catabolites.
Similar articles
-
In Schizophrenia, Increased Plasma IgM/IgA Responses to Gut Commensal Bacteria Are Associated with Negative Symptoms, Neurocognitive Impairments, and the Deficit Phenotype.Neurotox Res. 2019 Apr;35(3):684-698. doi: 10.1007/s12640-018-9987-y. Epub 2018 Dec 15. Neurotox Res. 2019. PMID: 30552634
-
Breakdown of the Paracellular Tight and Adherens Junctions in the Gut and Blood Brain Barrier and Damage to the Vascular Barrier in Patients with Deficit Schizophrenia.Neurotox Res. 2019 Aug;36(2):306-322. doi: 10.1007/s12640-019-00054-6. Epub 2019 May 10. Neurotox Res. 2019. PMID: 31077000
-
Upregulation of the Intestinal Paracellular Pathway with Breakdown of Tight and Adherens Junctions in Deficit Schizophrenia.Mol Neurobiol. 2019 Oct;56(10):7056-7073. doi: 10.1007/s12035-019-1578-2. Epub 2019 Apr 10. Mol Neurobiol. 2019. PMID: 30972627
-
Recognizing the Leaky Gut as a Trans-diagnostic Target for Neuroimmune Disorders Using Clinical Chemistry and Molecular Immunology Assays.Curr Top Med Chem. 2018;18(19):1641-1655. doi: 10.2174/1568026618666181115100610. Curr Top Med Chem. 2018. PMID: 30430944 Review.
-
The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression.Neuro Endocrinol Lett. 2008 Jun;29(3):287-91. Neuro Endocrinol Lett. 2008. PMID: 18580840 Review.
Cited by
-
Recent advancements in biomarker research in schizophrenia: mapping the road from bench to bedside.Metab Brain Dis. 2022 Oct;37(7):2197-2211. doi: 10.1007/s11011-022-00926-5. Epub 2022 Mar 3. Metab Brain Dis. 2022. PMID: 35239143 Review.
-
Metergoline Shares Properties with Atypical Antipsychotic Drugs Identified by Gene Expression Signature Screen.Neurotox Res. 2023 Dec;41(6):502-513. doi: 10.1007/s12640-023-00673-0. Epub 2023 Nov 3. Neurotox Res. 2023. PMID: 37922109 Free PMC article.
-
Association of elevated levels of peripheral complement components with cortical thinning and impaired logical memory in drug-naïve patients with first-episode schizophrenia.Schizophrenia (Heidelb). 2023 Nov 7;9(1):79. doi: 10.1038/s41537-023-00409-1. Schizophrenia (Heidelb). 2023. PMID: 37935744 Free PMC article.
-
In Schizophrenia, the Effects of the IL-6/IL-23/Th17 Axis on Health-Related Quality of Life and Disabilities Are Partly Mediated by Generalized Cognitive Decline and the Symptomatome.Int J Environ Res Public Health. 2022 Nov 18;19(22):15281. doi: 10.3390/ijerph192215281. Int J Environ Res Public Health. 2022. PMID: 36429996 Free PMC article.
-
First Episode Psychosis and Schizophrenia Are Systemic Neuro-Immune Disorders Triggered by a Biotic Stimulus in Individuals with Reduced Immune Regulation and Neuroprotection.Cells. 2021 Oct 28;10(11):2929. doi: 10.3390/cells10112929. Cells. 2021. PMID: 34831151 Free PMC article.
References
-
- Maes M, Vojdani A, Galecki P, Kanchanatawan B (2020) How to construct a bottom-up nomothetic network model and disclose novel nosological classes by integrating risk resilience and adverse outcome pathways with the phenome of schizophrenia. Brain Sci 10(9):645. https://doi.org/10.3390/brainsci10090645 - DOI - PMC
-
- Almulla AF, Al-Hakeim HK, Maes M (2020) Schizophrenia phenomenology revisited: positive and negative symptoms are strongly related reflective manifestations of an underlying single trait indicating overall severity of schizophrenia. CNS Spectr 20:1–10. https://doi.org/10.1017/S1092852920001182 Epub ahead of print - DOI
-
- Maes M, Vojdani A, Geffard M, Moreira EG, Barbosa DS, Michelin AP, Semeão LO, Sirivichayakul S et al (2019) Schizophrenia phenomenology comprises a bifactorial general severity and a single-group factor, which are differently associated with neurotoxic immune and immune-regulatory pathways. Biomol Concepts 10(1):209–225 - DOI - PubMed
-
- Maes M, Kanchanatawan B (2020) A generalized cognitive decline (GCoDe) partly mediates the effects of neuro-immune and neuro-oxidative toxicity on the symptomatome and lowered quality of life in (deficit) schizophrenia. Preprints 2020110523 https://doi.org/10.20944/preprints202011.0523.v1 .
-
- Kanchanatawan B, Sriswasdi S, Maes M (2019) Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia. Metab Brain Dis 34(1):267–282. https://doi.org/10.1007/s11011-018-0339-7 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous